- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Rheumatoid arthritis, or RA, is an autoimmune disease. It is an inflammatory condition, that causes painful swelling and that can affect more parts of the body than just joints. In some cases, this condition can damage a wide range of body systems, including skin, eyes, lungs, heart and blood vessels.
Showing 1–12 of 40 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
2023.02 |
223,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
2021.12 |
304,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
354,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
2024.02 |
354,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
355,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
2023.10 |
304,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
2024.06 |
304,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2022.09 |
274,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2025.03 |
274,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.04 |
272,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
6 mg |
-80°C |
2024.01 |
259,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.11 |
272,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
4 mg |
-80°C |
2019.02 |
234,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.04 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.06 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
4 mg |
-80°C |
2019.12 |
234,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2019.10 |
197,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
2020.04 |
197,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
2023.08 |
272,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Remsima® |
10 mg/mL |
– |
3 mg |
tba |
tba |
233,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.11 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2020.02 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2021.03 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2020.12 |
204,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
2025.01 |
239,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
2027.03 |
240,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Zessly® |
10 mg/mL |
– |
2 mg |
-80°C |
2022.10 |
241,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Truxima® |
10 mg/mL |
– |
2 mg |
tba |
tba |
234,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany